Reading Time: 10 minutesFor the purposes of this blog, ALS should be taken to mean ALS/MND. In September 2020 we published a blog article discussing Dr Rick Bedlack’s
Reading Time: 7 minutesResearchers from the University of Aberdeen and the University of Edinburgh have developed a new tool that could help to detect signs of MND in
Reading Time: 6 minutesWeight loss is a problem for many people living with MND, with approximately 20% of people already having lost 10% of their weight at diagnosis.
Reading Time: 7 minutesWeight loss is a problem for many people living with MND, with approximately 20% of people already having lost 10% of their weight at diagnosis.
Reading Time: 5 minutesWeight loss is a problem for many people living with MND, with approximately 20% of people already having lost 10% of their weight at diagnosis.
Reading Time: 5 minutesWeight loss is a problem for many people living with MND, with approximately 20% of people already having lost 10% of their weight at diagnosis.
Reading Time: 6 minutesWeight loss is a problem for many people living with MND, with approximately 20% of people already having lost 10% of their weight at diagnosis.
Reading Time: 4 minutesHello everyone. My name is Genevieve (Gen) and I have joined the Association as Philanthropy Information Officer. One of my roles is to communicate the
Reading Time: 5 minutesHi, I’m Ben, a researcher working at Sheffield University. I attended last year’s International Symposium on ALS/MND as one of the Symposium Communication Ambassadors and
Reading Time: 7 minutesHi, I’m Heather, a PhD student from King’s College London, and a Communications Ambassador for the 34th International Symposium on ALS/MND which was held in Basel last December. Over 1,300 attendees from around the world gathered to connect with researchers and people affected by MND and engage with the latest research presented in the platform presentation and poster sessions. In this blog post, I will be sharing several of my personal highlights of the symposium, which cover how differences in our genetic code can be explored to understand their effects on MND risk and progression.